Evidence map›Paper›PMID 25645853›Full record

ArticleAntimicrobial agents and chemotherapy2015

Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.

Kawthar Bouchemal, Armelle Aka-Any-Grah, Nathalie Dereuddre-Bosquet, Loïc Martin, Vanessa Lievin-Le-Moal, Roger Le Grand, Valérie Nicolas, Davide Gibellini, David Lembo, Christian Poüs and 2 more

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Kawthar BouchemalUniversité Paris-Sud, Institut Galien Paris Sud, UMR CNRS 8612, Faculté de Pharmacie, Châtenay-Malabry, France kawthar.bouchemal@u-psud.fr.
Armelle Aka-Any-GrahUniversité Paris-Sud, Institut Galien Paris Sud, UMR CNRS 8612, Faculté de Pharmacie, Châtenay-Malabry, France Université Félix Houphouet Boigny-Cocody, UFR des Sciences Pharmaceutiques et Biologiques, Laboratoire de Pharmacie Galénique, Biopharmacie et Législation, Abidjan, Côte d'Ivoire.
Nathalie Dereuddre-BosquetCEA, iMETI, Division of Immuno-Virology, Fontenay-aux Roses, France.
Loïc MartinCEA, iBiTecS, Service d'Ingénierie Moléculaire des Protéines (SIMOPRO), Gif sur Yvette, France.
Vanessa Lievin-Le-MoalAntiparasitic Chemotherapy, UMR CNRS 8076, Faculté de Pharmacie, Châtenay-Malabry, France.
Roger Le GrandCEA, iMETI, Division of Immuno-Virology, Fontenay-aux Roses, France.
Valérie NicolasUniversité Paris-Sud, IFR 141, Faculté de Pharmacie, Châtenay-Malabry, France.
Davide GibelliniDepartment of Pathology and Diagnostic, Microbiology and Virology Unit, University of Verona, Verona, Italy.
David LemboUniversity of Turin, Department of Clinical and Biological Sciences, S. Luigi Gonzaga Hospital Regione Gonzole, Orbassano, Turin, Italy.
Christian PoüsBiochimie et Biologie Cellulaire-JE2493, Université Paris-Sud, IFR 141, Faculté de Pharmacie, Châtenay-Malabry, France.
Armand KoffiUniversité Félix Houphouet Boigny-Cocody, UFR des Sciences Pharmaceutiques et Biologiques, Laboratoire de Pharmacie Galénique, Biopharmacie et Législation, Abidjan, Côte d'Ivoire.
Gilles PonchelUniversité Paris-Sud, Institut Galien Paris Sud, UMR CNRS 8612, Faculté de Pharmacie, Châtenay-Malabry, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To be efficient, vaginal microbicide hydrogels should form a barrier against viral infections and prevent virus spreading through mucus. Multiple particle tracking was used to quantify the mobility of 170-nm fluorescently labeled COOH-modified polystyrene particles (COOH-PS) into thermosensitive hydrogels composed of amphiphilic triblock copolymers with block compositions EOn-POm-EOn (where EO refers to ethylene oxide and PO to propylene oxide) containing mucoadhesive hydroxypropylmethylcellulose (HPMC). COOH-PS were used to mimic the size and the surface charge of HIV-1. Analysis of COOH-PS trajectories showed that particle mobility was decreased by Pluronic hydrogels in comparison with cynomolgus macaque cervicovaginal mucus and hydroxyethylcellulose hydrogel (HEC; 1.5% by weight [wt%]) used as negative controls. Formulation of the peptide mini-CD4 M48U1 used as an anti-HIV-1 molecule into a mixture of Pluronic F127 (20 wt%) and HPMC (1 wt%) did not affect its anti-HIV-1 activity in comparison with HEC hydrogel. The 50% inhibitory concentration (IC50) was 0.53 μg/ml (0.17 μM) for M48U1-HEC and 0.58 μg/ml (0.19 μM) for M48U1-F127-HPMC. The present work suggests that hydrogels composed of F127-HPMC (20/1 wt%, respectively) can be used to create an efficient barrier against particle diffusion in comparison to conventional HEC hydrogels.

Indexed as

AnimalsAnti-HIV AgentsCD4 AntigensCervix MucusDiffusionFemaleFluorescent DyesHIV-1HIV Fusion InhibitorsHIV InfectionsHumansHydrogelsHypromellose DerivativesMacaca fascicularisPoloxamerPolyethylene GlycolsAnti-HIV AgentsCD4 AntigensFluorescent DyesHIV Fusion InhibitorsHydrogelsHypromellose DerivativesPEO-PPO-PEOPoloxamerPolyethylene GlycolsPropylene Glycols

Identifiers

PMID25645853
PMCPMC4356805

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.